Group items tagged

The Green Party has previewed its upcoming manifesto with a bold proposal for the National Health Service (NHS) and social care system, promising an unprecedented level of investment to restore and enhance these critical services. By 2030, the Greens aim to inject over £50 billion annually into health and social care, accompanied by an additional £20 billion capital investment to modernise healthcare infrastructure. Green Party Co-Leader Adrian Ramsay emphasised the urgency of these reforms, stating, "Our NHS is at breaking point following 14 years of underfunding." "Patients are stuck in hospital corridors, people can't see their GP or NHS dentist when they need to, and staff are severely overstretched." The manifesto highlights a comprehensive approach to revitalising the NHS, including:

The efforts by people to look younger have been as old as humanity itself. Therefore, it comes as no surprise when people are using different techniques to achieve the looks of a younger person. Some people have been using facelifts recently as an instant treatment to look few years younger, but the effects are only temporary and there are no positive implications to a person's health.

Occupational Health Services gives a scope of services to secure wellbeing at work, evaluate and prompt on wellness for work. Intervax, Private BCG

In legal cases, DNA Testing performed by only registered nurses, doctors or accredited individuals. At Olive Health & Travel Clinic We offer pregnancy tests by a choice of blood test and urine test. Blood tests are more sensitive than urine tests so we prefer urine test for assurance.

Gefitinib Medicines, Erlotinib Tablets & Sorafenib Tosylate Exporter offered by Modern Times Helpline Pharma from New Delhi, Delhi, India

British drugmaker AstraZeneca said on Thursday (June 1) it would stop developing its drug brazikumab to treat inflammatory bowel diseases, including Crohn's disease and ulcerative colitis. The company said the discontinuation was due to a delay in the drug's development timeline, affected by global events and "the context of a competitive landscape". AstraZeneca regained the rights to brazikumab from Allergan in 2020 following U.S. drugmaker AbbVie's $63 billion tie-up with Allergan. AbbVie will stop funding the drug's development, AstraZeneca said. AbbVie's Skyrizi also treats Crohn's disease.

The NHS claims that it's been able to save taxpayers £1.2 billion in just three years by procuring hundreds of hospital medicines at a better price. The adoption of cheaper versions of a single drug - adalimumab - which is used to treat more than 45,000 patients with rheumatoid arthritis, inflammatory bowel disease and psoriasis, has accounted for about one third of the savings. After the exclusive patent on the drug - originally known as its brand name Humira - expired in 2018, the NHS struck cost-saving deals to bulk-buy generic versions, which have the same quality, safety and efficacy of a branded one. Since then, tens of millions of pounds have been saved by buying cheaper generic versions of other medicines for conditions ranging from severe skin infections to aggressive blood cancers. Four in five medicines prescribed in the NHS are now non-branded, helping the NHS to achieve significant savings while ensuring the continuity of high-quality patient care. NHS chief executive Amanda Pritchard said: "Smart deals by the NHS mean patients are getting the best medicines and taxpayers are getting best value.

Oxycontin OP 15 mg is a powerful prescription opioid pain medication that has been approved for use in the United States since 1996. It's highly addictive and has many side effects, but it also works well to relieve severe pain. Many people take OxyContin as their doctor prescribes, but others abuse it by taking too much or selling it on the street. Buy Oxycontin online Oxycontin is an opioid medicine used to manage mild to extreme pain and a popular abuse product marketed under the brand name OxyContin, among others. This is typically taken by mouth and is available in the formulation of immediate releases and controlled releases. The pain relief normally starts with the immediate release treatment within 15 minutes and lasts up to six hours. It is available through injection in the United Kingdom. Paracetamol, ibuprofen, naloxone, and aspirin are all used in prescription drugs. You can buy oxycontin online and get oxycontin for sale online. ​Buy oxycontin op 15 mg best quality pills online rx required. Buy OxycontinTop Quality pills by mail from Europe.

Oxycontin OC 80 mg is an opioid medicine used to manage mild to extreme pain and a popular abuse product marketed under the brand name OxyContin OC 80 mg among others. This is typically taken by mouth and is available in the formulation of immediate releases and controlled releases. The pain relief normally starts with the immediate release treatment within 15 minutes and lasts up to six hours. It is available through injection in the United Kingdom. Paracetamol, ibuprofen, naloxone, and aspirin are all used in prescription drugs. You can buy oxycontin OC 80 mg online and get oxycontin OC 80 mg for sale online. ​Buy oxycontin OC 80 mg best quality pills online. No rx required. Buy Oxycontin OC 80 mg Top Quality pills by mail from Europe. OxyContin is a powerful prescription opioid pain medication that's been approved for use in the United States since 1996. It's highly addictive and has many side effects, but it also works well to relieve severe pain. Many people take OxyContin as their doctor prescribes, but others abuse it by taking too much or selling it on the street.

Britain's GlaxoSmithKline will receive $1.25 billion (about £921 million) from Gilead Sciences as part of a settlement between its HIV medicines unit and the US-based drugmaker, ending a long-drawn patent dispute. The settlement, announced by GSK on Tuesday (February 1), relates to Gilead's antiretroviral drug Biktarvy, a medicine used to check the AIDS-causing virus, which GSK said in 2018 infringed on its unit ViiV Healthcare's dolutegravir and other similar compounds. HIV medicines developed by ViiV, in which Pfizer and Japan's Shionogi also hold small stakes, are a major part of GSK's plan to support its lagging pharmaceuticals business as it readies to spin off its consumer healthcare arm. The payment is expected to be made in the first quarter this year, London-listed GSK said. Gilead will also pay a 3 per cent royalty until 2027 on sales of Biktarvy and on future US sales of any product containing its main component.

Rowlands pharmacy has launched a new weight management service across its UK network, challenging perceptions around weight loss and providing expert support to those in need. The launch comprises a pilot roll-out across 100 Rowlands branches to increase consideration of pharmacies for weight management-based advice. Commenting on the launch, Nigel Swift, managing director of Rowlands, said: "One of the biggest challenges facing many adults looking to address any weight concerns is knowing where and how to start. Our new weight management service is designed to help all those setting out on a new weight loss journey but also those who have struggled to find a plan that works for them." "Our pharmacy teams offer comprehensive healthcare advice and a variety of weight management products with a friendly approach that naturally puts customers at ease, and we're looking forward to welcoming all those looking to take their first step with us."